Skip to main content

Table 2 Cumulative and absolute prevalence of the three IAD change strategies (switching, augmentation, and combination) at different time points (N = 431) #

From: Prevalence, median time, and associated factors with the likelihood of initial antidepressant change: a cross-sectional study in Qatar

Prevalence of IAD change at different time points

Cumulative prevalence (All strategies)

Absolute prevalence (All strategies)

Detailed cumulative prevalence expressed as frequency, percentages & 95% CI of each IAD change strategy

 

Switching

Augmentation

Combination

≤ 30 days

212 (49%)

[44–53%]

212 (49%)

[44–53%]

144 (68%)

[61–74%]

25 (12%)

[7.4–16%]

43 (20%)

[15–25%]

≤ 90 days

299 (69%)

[65–74%]

87 (20.2%)

[17–24%]

207 (69%)

[64–74%]

32 (11%)

[7–14%]

60 (20%)

[15–25%]

≤ 180 days

382 (88%)

[85–91%]

83 (19.2%)

[15–23%]

259 (68%)

[63–72%]

41 (11%)

[8–14%]

82 (21%)

[17–26%]

≥ 181 days *

431 (100%)

49 (11.4)

[8–14%]

294 (68%)

[64–73%]

46 (11%)

[7–14%]

91 (21%)

[17–25%]

  1. IAD Initial Antidepressant, CI Confidence Interval, # Number of patients with occurrence of IAD changes (i.e.: excluding censored patients); *to end of study